Jean Schwartz, APRN
Primary Care · Lebanon, NHNPI 1619337854
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,880 of the $9,216 with a category attached, or 63.8%. UCB, Inc. accounts for 72.7% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $5,858, 5.7 times the $1,033 reported in 2021. Among primary care clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $135.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$7K
- Biohaven Pharmaceutical Holding Company Ltd.$685
- Biohaven Pharmaceuticals, Inc.$541
- Bristol Myers Squibb$483
- SK Life Science, Inc.$173
- AbbVie$172
- plus $463 from 8 others
What the payments were for
- Consulting fees$5,88064%
- Travel & lodging$1,10612%
- Food & beverage$2,10823%
- Education$1211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 9 | $6,698 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $685 |
| Biohaven Pharmaceuticals, Inc. | 13 | $541 |
| Bristol Myers Squibb | 6 | $483 |
| SK Life Science, Inc. | 8 | $173 |
| AbbVie(2 entities) | 10 | $172 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| AstraZeneca(2 entities) | 3 | $106 |
| Biogen | 4 | $103 |
| GE HealthCare | 1 | $38 |
| Genentech USA, Inc. | 4 | $27 |
| Novartis | 2 | $27 |
| EMD Serono, Inc. | 1 | $25 |
| Amgen | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilbrysq$6,350
- NURTEC ODT$1,068
- ZEPOSIA$232
- AUSTEDO$113
- XCOPRI$110
How this compares
$9,216 in reported general payments places this provider in the 95th percentile of 31 primary care providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $356,541 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 16 | $141,583 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 22 | $94,212 |
| Pyridostigmine Bromide | 97 | $8,177 |
| Mycophenolate Mofetil | 64 | $7,695 |
| Gabapentin | 134 | $2,271 |
| Pregabalin | 51 | $1,879 |
| Duloxetine Hcl | 24 | $403 |
| Prednisone | 48 | $375 |
| Amitriptyline Hcl | 20 | $309 |
| Levetiracetam | 12 | $221 |
| Famotidine | 19 | $118 |
| Cyclobenzaprine Hcl | 20 | $32 |
Paid to pharmacies, not to this prescriber.
Other primary care in Lebanon
- Carole PutnamLebanon$23
- Beena RajagopalNashua$6K
- Kathleen DevejianHampstead$3K
- Kamila ZlotoschDurham$2K
- Deborah JensenHopkinton$801
- Tina McGuirkNashua$760
- Jennifer TichichLaconia$709
- Melissa-Jo NasonConway$704
- Stephane CampagnaLittleton$680
- Emily GrattanSomersworth$647
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.